Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
BioXyTran Logo
BioXyTran Growth Score
68
CB Rank
206057
Heat Score
54
BioXyTran is a biopharmaceutical company that develops treatments for stroke and Ischemia.
Founded
obfuscation
PublicPost-IPO Equity Needham, Massachusetts, United States11-50 www.bioxytraninc.com
Biotechnology
Health Care
Pharmaceutical
Overview

BioXyTran
Total Funding
obfuscation
Growth Score
68
Heat Score
54

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score68
-15 pts
in past quarter
Heat Score 54
-25 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About BioXyTran

CB Rank
206057
BioXyTran is a biopharmaceutical company that develops treatments for stroke and Ischemia.
Founded
obfuscation
PublicPost-IPO Equity Needham, Massachusetts, United States11-50 www.bioxytraninc.com
Biotechnology
Health Care
Pharmaceutical

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name BioXyTran, Inc.
Operating Status Active
Stock Symbol  OTCPINK:BIXT
Company Type For Profit
Founders  David Platt
About the Company
BioXyTran operates as a biopharmaceutical company whose mission is to develop anti-necrosis drugs that treat a variety of medical conditions resulting from stroke and Ischemia. The company was founded in 2008 and is headquartered in Needham, Massachusetts.
Phone Number 617-454-1199
Contact Email info@bioxytraninc.com
Predictions & Insights

Growth Insight

See this Growth Insight
BioXyTran is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

ProLectin-M
An oral antiviral drug designed to antagonize galectins involved in inflammatory, fibrotic, and malignant diseases, targeting viral infections including COVID-19.
BXT-25
A drug candidate delivering nanoscale oxygen carriers to tissues affected by hypoxia, aimed at treating conditions like stroke, trauma, and lung diseases.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 6
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - BioXyTran Logo
Post-IPO Equity - BioXyTran
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - BioXyTran Logo
Post-IPO Equity - BioXyTran
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - BioXyTran Logo
Post-IPO Equity - BioXyTran
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - BioXyTran Logo
Post-IPO Equity - BioXyTran
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - BioXyTran Logo
Post-IPO Equity - BioXyTran
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 6
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - BioXyTran Logo
Post-IPO Equity - BioXyTran
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - BioXyTran Logo
Post-IPO Equity - BioXyTran
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - BioXyTran Logo
Post-IPO Equity - BioXyTran
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - BioXyTran Logo
Post-IPO Equity - BioXyTran
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - BioXyTran Logo
Post-IPO Equity - BioXyTran
—
obfuscation
— Post-IPO Equity

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1 Contacts 3

Employee Profiles

News

News and Press

News•Mar 20, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 2, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 2, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 24, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

5,999
1,338.61%
 in past month

IT Spend

$13.8KThis year, BioXyTran is projected to spend $13.8K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Newegg Logo
Newegg
69
Meta Platforms, Inc. Logo
Meta Platforms, Inc.
69
Motorola Solutions (MSI) Logo
Motorola Solutions (MSI)
69

Active Website Tech Count

2BioXyTran is actively using 2 technologies for its website, according to BuiltWith. These include Euro and  Google Maps.

Total IP

2The intellectual property of BioXyTran includes 2 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is BioXyTran's headquarters? BioXyTran is located in Needham, Massachusetts, United States.Who invested in BioXyTran? BioXyTran is funded by TRITON FUNDS LLC.When was the last funding round for BioXyTran? BioXyTran closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are BioXyTran's competitors? Alternatives and possible competitors to BioXyTran may include Decoy Therapeutics, Lumen Bioscience, and  Faraday Pharmaceuticals.How much funding has BioXyTran raised to date? BioXyTran has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(4060bec 1)
|